Surgical Site Infection

2
Pipeline Programs
3
Companies
6
Clinical Trials
1
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket

On Market (1)

Approved therapies currently available

U
AMPICILLIN SODIUMApproved
ampicillin
Unknown Company
injection1993

Competitive Landscape

3 companies ranked by most advanced pipeline stage

Takeda
TakedaTOKYO, Japan
1 program
1
AmpicillinPhase 41 trial
Active Trials
NCT06368102Completed70Est. Sep 2025
Verona Pharma
Verona PharmaUK - London
3 programs
AlexisN/A1 trial
Antibiotic Stewardship ProgramN/A1 trial
Disposable negative wound pressure deviceN/A1 trial
Active Trials
NCT03820648Terminated212Est. Dec 2019
NCT04199494Unknown1,200Est. Dec 2022
NCT03700086Completed100Est. Oct 2019
Getinge
GetingeChina - Suzhou
2 programs
Conventional ventilation + instrumental tables with integrated laminar airflowN/A1 trial
Investigation of Environmental Parameters in Operating RoomsN/A1 trial
Active Trials
NCT04676841Unknown100Est. Nov 2022
NCT05816135Unknown5,000Est. Dec 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
TakedaAmpicillin
GetingeInvestigation of Environmental Parameters in Operating Rooms
Verona PharmaAntibiotic Stewardship Program
GetingeConventional ventilation + instrumental tables with integrated laminar airflow
Verona PharmaDisposable negative wound pressure device
Verona PharmaAlexis

Clinical Trials (6)

Total enrollment: 6,682 patients across 6 trials

NCT06368102TakedaAmpicillin

Prophylactic Effects for Preventing Surgical Site Infection in Third Molar Surgery

Start: May 2024Est. completion: Sep 202570 patients
Phase 4Completed
NCT05816135GetingeInvestigation of Environmental Parameters in Operating Rooms

Investigation of Environmental Parameters in Operating Rooms

Start: Jan 2021Est. completion: Dec 20235,000 patients
N/AUnknown
NCT04199494Verona PharmaAntibiotic Stewardship Program

Antibiotic Stewardship Program in Pancreatic Surgery: a Multicenter Time Series Analysis (BIOSTEPS).

Start: Dec 2019Est. completion: Dec 20221,200 patients
N/AUnknown
NCT04676841GetingeConventional ventilation + instrumental tables with integrated laminar airflow

Wound Contamination During Orthopaedic Surgery

Start: Sep 2019Est. completion: Nov 2022100 patients
N/AUnknown
NCT03700086Verona PharmaDisposable negative wound pressure device

Efficacy of NPWT in Reducing the Incidence of Wound Infection After Pancreatic Surgery

Start: Jul 2018Est. completion: Oct 2019100 patients
N/ACompleted
NCT03820648Verona PharmaAlexis

Wound Protector Dual-ring Alexis® in Pancreaticoduodenectomy

Start: Sep 2017Est. completion: Dec 2019212 patients
N/ATerminated

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

3 companies competing in this space